While EIF4G2 seems to be a promising target, its effects on CRC cell growth and death will need to be further elucidated in cell studies and more physiologically relevant 3D models such as organoids before proceeding to animal studies [72]. This evidence concerns the gene EIF4G2 and colorectal carcinoma.